Seeking Alpha

Santarus Inc. (SNTS)

()

Comments on SNTS

  • Santarus' Zegrid Facing Back-to-Back FDA Approval Dates [View article]
    this was posted word for word on biomedreports.com i think im on to something? ugh dat sucks...
    Comment by Hustle617
    Dec 2 12:10 pm |
    Rating: 0 0
  • AH: Shares of SNTS Explode! ]]]] +34% [[[[ [View instapost]
    Thanks Justin! To top this, SNTS has another FDA action date on December 9th for Zegerid. Regards, Charlie
    Comment by lyme3m
    Dec 2 10:30 am |
    Rating: 0 0
  • Santarus' Zegrid Facing Back-to-Back FDA Approval Dates [View article]
    Congratulations to all who followed this one. On the question about time between approval and launch, nobody really knows, but the... More »
    Comment by R. Saito
    Dec 1 18:17 pm |
    Rating: 0 0
  • Santarus, Depomed Poised to Gain from Anticipated Sales of Glumetza [View article]
    Sorry, here are the... More »
    Nov 20 13:57 pm |
    Rating: +1 0
  • Santarus, Depomed Poised to Gain from Anticipated Sales of Glumetza [View article]
    I am sorry, but this article is grossly incorrect and inaccurate. Even if glumetza commands the entire "branded metformin" market, it... More »
    Nov 20 13:56 pm |
    Rating: +1 0
  • Santarus' Zegrid Facing Back-to-Back FDA Approval Dates [View article]
    Why didn't OTC get approved initially? How long between approval and launch? With capsule and powder versions already available, how... More »
    Comment by Tina L
    Nov 20 11:14 am |
    Rating: +1 0
  • RxNews Recap for Tuesday 11-10-09 [View instapost]
    Thanks for the heads up. Just added him/her to my list!
    Comment by M. E. Garza
    Nov 12 04:01 am |
    Rating: 0 0
  • RxNews Recap for Tuesday 11-10-09 [View instapost]
    Oops! please white out, "...not only," in the above comment.
    Comment by Mayascribe
    Nov 11 16:41 pm |
    Rating: +1 0
  • RxNews Recap for Tuesday 11-10-09 [View instapost]
    M.E.Garza: Thanks for the undate. Question: Are you aware that right here on SA someone is doing an incredible job concentrating all... More »
    Comment by Mayascribe
    Nov 11 16:40 pm |
    Rating: +1 0
  • Santurus (SNTS): A Good Buy [View instapost]
    I agree. I think if it can penetrate $4, then it's on!
    Comment by Justin M. Hall
    Nov 9 11:39 am |
    Rating: +1 0
  • Santurus (SNTS): A Good Buy [View instapost]
    the 4.25 break will be huge....*check the chart*
    Comment by Hustle617
    Nov 9 11:37 am |
    Rating: +1 0
  • Extreme FDA Trades: 30 Stocks Under 5 Bucks [View article]
    Mike, Thanks for the article. What's your take on Neopharma (Neol.pk). I read on article on Biomedreports that there are many pending... More »
    Comment by sdmy123
    Oct 1 10:58 am |
    Rating: 0 0
  • Extreme FDA Trades: 30 Stocks Under 5 Bucks [View article]
    intranasal ketamine? really? Thanks for this info, this is interesting. I had no idea anyone was developing ketamine for this purpose. ... More »
    Comment by drbob66
    Sep 22 17:26 pm |
    Rating: 0 0
  • Pending FDA Decisions: 20 Extreme Trades [View article]
    Thanks mike, all your posts are big help, are you updating this list any time soon?, please let us know. Thanks again!
    Comment by santy
    Sep 12 09:20 am |
    Rating: 0 0
  • Extreme FDA Trades: 30 Stocks Under 5 Bucks [View article]
    ok what is your take on biel now 8-25-09
    Comment by DuckThis
    Aug 25 18:08 pm |
    Rating: 0 0